Safety testing and regulation of genetically engineered foods

Biotechnology and Genetic Engineering Reviews

Volumn 21, Issue 1, 2004, Pages 299-324

  Freese, William ^a   Schubert, David ^b  

^a Friends of the Earth   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ENGINEERING;

SAFETY TESTING;

PROTEIN;

ALLERGENICITY; AMES TEST; BACILLUS THURINGIENSIS; CORN; ENVIRONMENTAL PROTECTION; FOOD AND DRUG ADMINISTRATION; FOOD SAFETY; GENETICALLY MODIFIED CROP; GOVERNMENT; POLICY; RECOMBINANT DNA TECHNOLOGY; REVIEW; UNITED STATES; WORLD HEALTH ORGANIZATION;

BACILLUS THURINGIENSIS; ZEA MAYS;

EID: 10644254759     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.1080/02648725.2004.10648060     Document Type: Article

References (96)

1. Alibhai, M.F. and Stallings, W.C. (2001). Closing down on glyphosate inhibition - with a new structure for drug discovery. Proceedings of the National Academy of Sciences of the United State of America98(6), 2944–2946
2. Ames, B.N., Profet, M. and Gold, L.S. (1990). Dietary pesticides (99.99% all natural). Proceedings of the National Academy of Sciences of the United States of America87, 7777–7781
3. Behle, R.W., McGuire, M.R. and Shasha, B.S. (1997). Effects of sunlight and simulated rain on residual activity of Bacillus thuringiensis fomlulations. Journal of Economic Entomology90, 1560–1566
4. Benbrook, C. (2001). Troubled times amid commercial success for Roundup Ready soybeans. AgBiotech InfoNet Technical Paper No.4, May 3, 2001. http://www.biotech-info.net/troubledtimes.html
5. Benbrook, C. (2003). Impacts of genetically engineered crops on pesticide use in the United States:the first eight years. Biotech InfoNet Technical Paper No.6, November 2003. http://www.biotech-info.net/technicalpaper6.html
6. Bernstein, I.L., Bernstein, J.A., Miller, M. et al. (1999). Immune responses in farm workers after exposure to Bacillus thuringiensis pesticides. Environmental Health Perspectives107(7), 575–582
7. Caplan, R. (2003). Raising risk:field testing of genetically engineered crops in the UnitedStates. US PIRG Education Fund, June 2003. http://www.uspirg.org/reports/RaisingRisk/2003.pdf
8. Council (1991). Report on national biotechnology policy 11. The President’s Council on Competitiveness, Washington, DC, USA
9. Courtial, B., Feuerbach. F., Eberhard, S. et al. (2001). Tnt 1 transposition events are induced by in vitro transformation of Arabidopsis thaliana, and transposed copies integrate into genes. Molecular Genetics and Genomics265, 32–42
10. Daily Democrat (2003). Biotech battle takes shape in capital. Daily Democrat, Woodland, CA, USA, June 23, 2003
11. Dalton, R. (2002). Superweed study falters as seed firms deny access to transgene. Nature419 (6908), 655
12. EC (2000). Risk assessment in a rapidly evolving field:the case of genetically modified plants (GMP). Scientific Opinion of the Scientific Steering Committee, Health and Consumer Protection Directorate-General, European Commission, October 26–27, 2000, p. 9
13. EC(2003). European legislative framework for GMOs is now in place. Press Release IP/03/l056, European Commission, July 22, 2003. http://europa.eu.int/rapid/start/cgi/guesten.ksh?p_action.gettxt=gt&doc=IP/03/1056101RAPID&lg=EN
14. Edmonds Institute (1998). Manual for assessing ecological and human health effects of genetically engineered organisms. The Edmonds Institute. http://www.edmonds-institute.org/manual.html
15. Eichenwald, K., Kolata, G. and Petersen, M. (2001). Biotechnology food:from the lab to a debacle. New York Times January 25, 2001, pp. A1, C6–C7
16. Elgorashi, E.E., Taylor, J.L.S., Maes, A., VanStaden, J., deKimpe, N. and Verschaeve, L. (2003). Screening of medicinal plants used in South African traditional medicine for genotoxic effects. Toxicology Letters143, 195–207
17. th September, 2003, 55833–55849
18. EPABRAD (2001a). Biopesticides Registration Action Document(BRAD)-Bacillus thuringiensis plant-incorporated protectants:environmental assessment, US EPA, October 15, 2001, p. IIC34. http://www.epa.gov/pesticides/biopesticides/pips/bt_brad2/3ecological.pdf
19. EPABRAD(2001b). Biopesticides Registration Action Docunlent(BRAD) - Bacillus thuringiensis plant-incorporated protectants:product characterization and human health assessment, US EPA, October 15, 2001. http://www.epa.gov/pesticides/biopesticides/pips/bt_brad2/2-id_health.pdf
20. EPABRAD(2001c). Biopesticides Registration Action Document(BRAD)-Bacillus thuringiensis Cry 1F corn, US EPA, August 2001, p. 9. http://www.epa.gov/pesticides/biopesticides/ingredients/tech_docs/brad_006481.pdf
21. EPABRAD(2001d). Biopesticides Registration Action Document(BRAD)-Bacillus thuringiensis plant-incorporated protectants:overview, US EPA, October 15,2001. http://www.epa.gov/pesticides/biopesticides/pips/bt_brad2/1-overviepw.pdf
22. EPABRAD(2001e). Biopesticides Registration Action Document(BRAD) - Bacillus thuringiensis plant-incorporated protectants:insect resistance management, US EPA, October 15, 2001, p. IID2. http://www.epa.gov/pesticides/biopesticides/pips/bt_brad2/4-irm.pdf
23. th July, 2001, 37771–37817. http://www.epa.gov/scipoly/pips.htm
24. EPA Rule(1992), Pesticide tolerances and food and feed additive regulations for glyphosate:final rule. Federal Register Vol. 57, 42700
25. rd November, 1994. http://www.pestlaw.com/x/fedreg/1994/EPA-19941123A.html
26. FAO-WHO (2001). Evaluation of allergenicity of genetically modified foods. Report of a joint FAO/WHO expert consultation on allergenicity of foods derived from biotechnology. January 22–25, 2001. http://www.fao.org/es/ESN/food/pdf/allergygm.pdf
27. FDA Letter (1996). Letter from Alan M. Rulis, Office of Premarket Approval, Center for Food Safety and Applied Nutrition, FDA to Dr. Kent Croon, Regulatory Affairs Manager, Monsanto Company, September 25, 1996. See Letter for BNF No. 34 at http://www.cfsan.fda.gov/~lrd/biocon.html
28. FDA Memo (1991). ‘Points to consider for safety evaluation of genetically modified foods. Supplemental infomlation.’ Memo from Division of Food Chemistry and Technology and Division of Contaminants Chemistry, FDA, to James Maryanski, Biotechnology Coordinator, FDA. November 1,1991. http://www.bio-integrity.org/FDAdocsl10/10.pdf
29. FDA Memo (1992a). ‘Revision of toxicology section of the Statement of policy:foods derived from genetically modified plants.’ Memo from Samuel I. Shibko, Director, Division of Toxicological Review and Evaluation, FDA to James Maryanski, Biotechnology Coordinator, FDA. January 31, 1992. http://www.bio-integrity.org/FDAdoes/03/03.pdf
30. FDA Memo(1992b). ‘Comments on biotechnology draft document, 2/27/92.’ Draft memo from Dr. Louis J. Pribyl (recipient not cited). 3/6/92. http://www.bio-integrity. org/FDAdocs/04/04.pdf
31. FDA Memos. FDA Memos 1991, 1992a and 1992b above are 3 of 24 internal FDA documents obtained in a Freedom of Information Act request by the Alliance for Bio-Integrity. See http://www.bio-integrity.org/list.html
32. FDA Note (1996). FDA consultation note on Monsanto’s MON809 and MON810 Bt corn events. September 18, 1996. See memo for BNF No. 34 at http://www.cfsan.fda.gov/~lrd/biocon.html
33. FDA Note (1998). FDA consultation note on Monsanto/Novartis’ glyphosate-tolerant sugar beet line 77. September 28, 1998. See memo for BNF No. 56 at http://www.cfsan.fda.gov/~lrdl/biocon.html
34. FDA Note (2000). FDA consultation note on Aventis’ male-sterile corn, MS6 line.April4,2000. See memo for BNF No. 66 at http://www.cfsan.fda.gov/~Ird/biocon.html
35. th May, 1992, 22983–23005
36. Ferber, D. (2003). Something funny down on the phann. Popular Science April 2003, 78–84
37. Freese, B. (2001). A critique of the EPA’s decision to reregister Bt crops and an examination of the potential al1ergenicity of Bt proteins. Adapted from comments of Friends of the Earth to the EPA, Docket No. OOP-00678B, Dec. 9, 2001. http://www.foe.org/safefood/colnlnenls.pdf
38. Freese, B. (2002). Suggestions for improvement of the FDA’s assessment of genetically engineered crops, including assessment of the potential allergenicity of novel, recombinant proteins. Presentation to FDA’s Food Biotechnology Subcommittee by Friends of the Earth, August 14, 2002. http://www.toe.org/camps/colnm/safefood/gefood/index.html
39. Freese, B. (2003). Genetically engineered crop health impacts evaluation - GAPS analysis. Friends of the Earth, Washington, DC, USA. http://www.foe.org/safefood/gapseval.pdf
40. Gendel, S. (1998). The use of amino acid sequence alignments to assess potential allergenicity of proteins used in genetically modified foods. Advances in Food and Nutrition Research42, 45–62
41. Gepts, P. (2002). A comparison between crop domestication, classical plant breeding, and genetic engineering. Crop Science 42, 1780–1790
42. Gurian-Sherman, D. (2003). Holes in the biotech safety net:FDA policy does not assure the safety of genetically engineered foods. Center for Science ill the Public Interest, January 2003, pp. 4–5. http://www.cspinet.org/new/pdf/fda_report_final.pdf
43. Harrison, L.A., Bailey, M.R., Naylor, M.W. et al. (1996). The expressed protein in glyphosate-tolerant soybean, 5-enolpyruvylshikimate-3-phosphate synthase from Agrobacterium Sp. Strain CP4, is rapidly digested in vitro and is not toxic to acutely gavaged Juice. The Journal of Nutrition126, 728–740
44. Haslberger. A.G. (2003). Codex guidelines for GM foods include the analysis of unintended effects. Nature Biotechnology21(7), 739–741
45. Hilbeck, A. and Meier, M.S. (2002). Critique of Monsanto’s environmental safety assessment for Cry3Bb Bt Corn. Ecostrat GmbH. Submitted to EPA on behalf of the Union of Concerned Scientists. http://www.ucsusa.org/publication.cfm?pllblicationID=480
46. Hilbeck, A., Meier, M.S. and Raps, A. (2000). Non-target organisms and Bt plants:report to Greenpeace International. EcoStrat GmbH, April 2000. http://www.greenpeaceusa.org/media/press_releases/gmo-report-complete.pdf
47. Howitz, K.T., Bitterman, K.J., Cohen, H.Y. ETAL. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature425, 191–196
48. Humphreys, J.M. and Chapple, C. (2002). Rewriting the lignin roadmap. Current Opinions in Plant Biology5, 224–229
49. Ignoffo, C.M. and Garcia, C. (1978). UV-photoinactivation of cells and spores of Bacillus thuringiensis and effects of peroxidase on inactivation. Environmenttal Entomology7, 270–272
50. Linskaya, O.N. and Vamvakas, S. (1997). Nephrotoxic effects of bacterial ribonucleases in the isolated perfused rat kidney. Toxicology120(1), 55–63
51. James, C. (2002). Global status of commercialized transgenic crops:2002. ISAAA Briefs No. 27:The International Service for the Acquisition of Agri-biotech Applications, Ithaca, NY, USA
52. Kilman, S. (2000). McDonald’s other fast-food chains pull Monsanto’s bio-engineered potato. Wall Street Journal April 28, 2000
53. Kleter, G.A. and Peijnenburg, Ad A.C.M. (2002). Screening of transgenic proteins expressed in transgenic food crops for the presence of short amino acid sequences identical to potential, IgE-binding linear epitopes of allergens. BMC Structural Biology2(8), 1–11. http://www.biomedcentral.comJI472-680712/8
54. Kok, E.J. and Kuiper, H.A. (2003). Comparative safety assessment for biotech crops. Trends in Biotechnology21, 439–444
55. Kota, M., Daniell, H., Varma, S., Garczynski, S.F, Gould, F. and Moar, W.J. (1999). Overexpression of the Bacillus thuringiensis (Bt) Cry2Aa2 protein in chloroplasts confers resistance to plants against susceptible and Bt-resistant insects. Proceedings of the National Academy of Sciences of the United States of America96,1840–1845
56. Kuiper, H.A., Kleter, G.A., Noteborn, H.P.J.M. and Kok, E.J. (2001). Assessment of the food safety issues related to genetically modified foods. The Plant Journal27(6), 503–528
57. Lappé, M. and Bailey, B. (1998). Against the grain:biotechnology and the corporate takeover of your food Pp. 75–76. Monroe, ME, USA:Common Courage Press
58. Lappé, M.A., Bailey, E.B., Childress, C. and Setchell, K.D.R. (1998). Alterations in clinically important phytoestrogens in genetically modified, herbicide-tolerant soybeans. Journal of Medicinal Food1, 241–245
59. Lee, T.C. and Bailey, M. (1995). Assessment of the equivalence of B.t.k. HD-1 protein produced in several insect protected com lines and Escherichia coli. Unpublished study submitted to the EPA by Monsanto. EPA MRID No. 436655–03
60. Lee, T.C., Bailey, M., Sims, S. et al. (1995). Assessment of the equivalence of the Bacillus thuringiensis subsp. kurstaki HD-1 protein produced in Escherichia coli and European corn borer resistant corn. Unpublished study submitted to the EPA by Monsanto. EPA MRID No. 435332–04
61. Levine, R., Groth, M., Kama, J. et al. (1995). Molecular characterization of insect protected corn line MON 810. Unpublished study submitted to the EPA by Monsanto, EPA MRID No. 436655–01C
62. Maggi, V.L. and Sims, S.R. (1994). Evaluation of the dietary effects of purified B.t.k endotoxin proteins on honey bee adults. California Agricultural Research, Inc. Unpublished study submitted to the EPA by Monsanto, EPA MRID No. 434392–03
63. Maron, D.M. and Ames, B.N. (1983). Revised methods for the Salmonella mutagenicity test. Mutation Research113,173–215
64. Meldrum, B. (1993). Amino acids as dietary excitotoxins:a contribution to understanding neurodegenerative disorders. Brain Research 18, 293–314
65. Mendelsohn, M., Kough, J., Vaituzis, 2. and Matthews, K. (2003). Are Bt Crops Safe? Nature Biotechnology21(9), 1003–1009 (see p. 1009, Table 6)
66. Metcalfe, D.D., Astwood, J.D., Townsend, R., Sampson, H.A., Taylor, S.L. and Fuchs, R.L. (1996). Assessment of the allergenic potential of foods derived from genetically engineered crop plants. Critical Reviews in Food Science and Nutrition36(S), S165–186
67. Meyer, P. (1999). The role of chromatin remodelling in transgene silencing and plant development. In Vitro Cellular and Developmental Biology- Plant35, 29–36
68. NAS (2000). Genetically modified pest-protected plants:science and regulation. Committee on Genetically Modified Pest-Protected Plants, National Research Council, National Academy of Sciences, Washington, DC, USA:National Academy Press, http://books.nap.edu/catalog/9795.html
69. NAS (2002). Environmental effects of transgenic plants:the scope and adequacy of regulation. Committee on Environmental Impacts associated with Commercialization of Transgenic Plants, National Research Council, National Academy of Sciences, Washington, DC, USA:National Academy Press, http://books.nap.edu/catalog/10258.html
70. NASS (2003). Acreage. National Agricultural Statistics Service, Economic Research Service, US Department of Agriculture, June 30, 2003. http://usda.mannlib.comell.edu/reports/nassr/field/pcp-bba/acrg0603.pdf
71. Noteborn, H.P.J.M. (1998). Assessment of the stability to digestion and bioavailability of the LYS mutant Cry9C protein from Bacillus thuringiensis serovar tolworthi. Unpublished study submitted to the EPA by AgrEvo, EPA MRID No. 447343–05. (Note:Noteborn also tested Cry lAb for purposes of comparison.)
72. t van den Berg, J.H.J. et al. (1995). Safety assessment of the Bacillus thuringiensis insecticidal crystal protein CRYIA(b) expressed in transgenic tomatoes. In:Genetically modified foods:safety issues. Eds. K.-H. Engel, G.R. Takeoka and R. Teranishi, pp. 134–147. Washington, DC, USA:American Chemical Society Symposium Series 605
73. th June, 1986, 23302 ff
74. Ream, J.E. (1994). Assessment of the in vitro digestive fate of Bacillus thuringiensis subsp. kurstaki HD-1 protein. Unpublished study submitted to the EPA by Monsanto. EPA MRID No. 434392–01
75. Roessner, U., Luedemann, A., Brust, D. et al. (2001). Metabolic profiling allows comprehensive phenotyping of genetically or environmentally modified plant systems. The Plant Cell13, 11–29
76. RS Canada (2001). Elements of precaution:recommendations for the regulation of food biotechnology in Canada, an expert panel report on the future of food biotechnology. Royal Society of Canada, p. 122. http://www.rsc.ca/foodbiotechnology/index/EN.html
77. SAP Bt (2000). Bt plant-pesticides risk and benefit assessments, Fifra Scientific Advisory Panel. SAP Report No. 2000–07. http://www.epa.gov/scipoly/sap/2000/october/octoberfinal.pdf
78. SAP MT (2000). Mammalian toxicity assessment guidelines for protein plant pesticides. FIFRA Scientific Advisory Panel. SAP Report No. 2000–03B. http://www.epa.gov/scipoly/sap/2000/june/finbtmamtox.pdf
79. SAP StarLink (2001). Assessment of additional scientific information concerning StarLink corn. FIFRA Scientific Advisory Panel. SAP Report No. 2001–09, pp. 29, 35. http://www.epa.gov/oscpmont/sap/2001/juiy/julyfinal.pdf
80. Saxena, D. and Stotzky, G. (2001). Bt corn has a higherlignin content than non-Bt corn. American Journal of Botany88(9), 1704–1706
81. Schmelz, E.A., Engelberth, J., Alborn, H.T. et al. (2003). Simultaneous analysis of phylohormones, phytotoxins, and volatile organic compounds in plants. Proceedings of the National Academy of Sciences of the United States of America100, 109552–109557
82. Schubert, D. (2002). A different perspective on GM food. Nature Biotechnology20, 969
83. Smith, N., Kilpatrick, J.B. and Whitelam, G.C. (2001). Superfluous transgene integration in plants. Critical Reviews in Plant Sciences20, 215–249
84. Trethewey, R.N., Krotzky, A.J. and Willmitzer, L. (1999). Metabolic profiling:a Rosetta Stone for genomics? Current Opinion in Plant Biology2, 83–85
85. USDA Compliance (2003). What is the compliance history with APHIS’ biotechnology regulations? USDA Animal and Plant Health Inspection Service, posted October 2003. hup://Avww.aphis.usda.gov/brs/compliance9.html
86. th September, 2003 from http://www.nbiap.vt.edu/cfdocs/biopetttionsl.cfm
87. USDA Determination (1998). Determination of non-regulated status for glufosinate-tolerant rice, in response to AgrEvo’s petition for deregulation of Liberty Link rice, Petition 98–329-01 p. http://www.aphis.usda.gov/biotech/dec_docs/9832901 p_det_ea.HTM
88. USDA EA (1996). Environmental assessment and finding of no significant impact for permit No. 96–355-01 granted to Applied Phytologics, Inc. for a field trial of biopharmaceutical rice conducted in California in 1997. http://www.isb.vt.edu/biomon/relea/9635501r.eaa
89. USDA Field Trial Website. Information systems for biotechnology, field test releases in the US. Searchable database of GE crop field trials:http://www.nbiap.vt.edu/cfdocs/fieldtestslxfrn
90. th March, 2003, 11337–11340
91. USDA Performance (2001). Meeting the performance standards in 7 CFR 340.3(c). http://www.aphis.usda.gov/bbep/bp/perstds.htm
92. Vazquez-Padrón, R.I., Moreno-Fierros, L., Neri-Bazán, L., de la Riva, G.A. and López-Revilla, R. (1999a). Intragastric and intraperitoneal administration of Cry 1 Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice. Life Sciences64(21), 1897–1912
93. Vázquez, R.I., Moreno-Fierros, L., Neri-Bazán, L., de la Riva, G.A. and López-Revilla, R. (1999b). Bacillus thuringiensis Cry 1 Ac protoxin is a potent systemic and mucosal adjuvant. Scandinavian Journal of Immunology49,578–584
94. Vázquez-Padrón, R.L, Moreno-Fierros, L., Neri-Bazán, L., de la Riva, G.A. and López-Revilla, R. (2000a). Characterization of the mucosal and systemic immune response induced by Cry 1 Ac protein from Bacillus thuringiensis HD 73 in mice. Brazilian Journal of Medical and Biological Research33,147–155
95. Vázquez-Padrón, R.L, Gonzales-Cabrera, J., Garcia-Tovar, C. et al. (2000b). Cry 1 Ac protoxin from Bacillus thuringiensis sp. kurstaki HD73 binds to surface proteins in the mouse small intestine. Biochemical and Biophysical Research Communications271, 54–58
96. Wal, J.M. (1998). Strategies for assessment and identification of altergenicity in (novel) foods. International Dairy Journal8,413–423